Latest United States Startup Funding Rounds

Startup funding in United States: recent rounds, the companies behind them and their participating investors.

This page showsCountry: United States
Rounds
2,598
All time
Disclosed funding
$634.9B
2148 disclosed amounts
Median round
$25M
Of disclosed amounts
2,598 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
FlywheelHealthtech · United StatesCompany profile

Medical imaging data management and analysis platform

Medical imaging data management and analysis platform

$27.5MUndisclosedHealthtechUnited StatesInvestors
EpiBiologicsBiotech · United StatesCompany profile

Develops bispecific antibodies for targeted degradation of extracellular proteins.

Develops bispecific antibodies for targeted degradation of extracellular proteins.

$107MSeries BBiotechUnited StatesInvestors
Parabilis MedicinesBiotech · United StatesCompany profile

Develops medicines targeting historically undruggable protein targets in cancer

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries FSeries C+BiotechUnited StatesInvestors
Articul8AI · United StatesCompany profile

Develops specialized AI systems for regulated industries

Develops specialized AI systems for regulated industries

$70MSeries BAIUnited StatesInvestors
Nocion TherapeuticsBiotech · United StatesCompany profile

Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch.

Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch.

$23MSeries B+Series BBiotechUnited StatesInvestors
Undisclosed
STRM.BIOBiotech · United StatesCompany profile

Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy

Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy

$8MSeed2SeedBiotechUnited StatesInvestors
Poplar TherapeuticsHealthtech · United StatesCompany profile

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

$50MSeries AHealthtechUnited StatesInvestors
Mediar TherapeuticsBiotech · United StatesCompany profile

Develops therapies to halt fibrosis in multiple organ systems

Develops therapies to halt fibrosis in multiple organ systems

$76MSeries BBiotechUnited StatesInvestors
Prudentia SciencesBiotech · United StatesCompany profile

Provides AI-native due diligence for life sciences dealmaking

Provides AI-native due diligence for life sciences dealmaking

$20MSeries ABiotechUnited StatesInvestors
Rakuten MedicalBiotech · United StatesCompany profile

Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment

Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment

$100MSeries FSeries C+BiotechUnited StatesInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    Y Combinator (YC)

    Unsiloed AI, Science Corporation, Garage

    140rounds
    3led
  2. 2
    Andreessen Horowitz (a16z)

    Larridin, Northwood Space, Tutor Intelligence

    126rounds
    31led
  3. 3
    General Catalyst

    Rox, Mercor, Nominal

    95rounds
    15led
  4. 4
    Sequoia Capital

    LangChain, Rox, Nominal

    75rounds
    17led
  5. 5
    Khosla Ventures

    Science Corporation, Imprint, Coframe

    69rounds
    9led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic